I remain bullish on Aurora Cannabis (ACB) over the long term, as the company improves its cost structure while positioning itself to drive sales from derivatives in the current quarter.In this article, I want to focus on the positive growth catalysts that are visible, and where the company could surprise to the upside if the narratives plays out.The ObviousMost investors following Aurora Cannabis and other Canadian cannabis companies are aware of the limitations on their short-term growth prospects as a result of the slow licensing process in Canada and the resultant shortage of retail stores to sell cannabis out of.While …read more
Source:: Yahoo Finance
